Akorn, Inc. Announces Third Quarter 2006 Earnings Release and Conference Call Information

  
    
  
  
    
      Akorn, Inc. (AMEX:AKN) announced today that its third quarter 2006 
      earnings release has been scheduled for Monday, October 30, 2006, at 
      4:00 p.m. (Eastern Time). The Company will also publish the earnings 
      release on its website at www.akorn.com. 
      In addition, Arthur S. Przybyl, President and Chief Executive Officer, 
      and Jeffrey A. Whitnell, Chief Financial Officer, will host an earnings 
      conference call Monday, October 30, 2006, beginning at 5:00 p.m. 
      (Eastern Time). The dial-in numbers are [phone] for domestic 
      callers and [phone] for international callers.
    
    
      
        
          What:
        
        
        
        
          Akorn, Inc. Third Quarter 2006 Earnings Conference Call
        
      
      
        
        
        
        
        
           
        
      
      
        
          When:
        
        
        
        
          Monday, October 30, 2006 at 5:00 p.m., Eastern Time
        
      
      
        
        
        
        
        
           
        
      
      
        
          Website:
        
        
        
        
          
            Live webcast available at www.akorn.com 
            or
          
        
      
      
        
        
        
        
        
          
            http://www.videonewswire.com/event.asp?id=35878
          
        
      
      
        
        
        
        
        
           
        
      
      
        
          
            Call-in #:
          
        
        
        
        
          [phone] for domestic callers
        
      
      
        
        
        
        
        
          [phone] for international callers
        
      
      
        
        
        
        
        
           
        
      
      
        
        
        
        
        
          A replay of the conference call will be posted on the Company's 
          website for 30 days following the call.
        
      
    
    
      About Akorn, Inc.
    
    
      Akorn, Inc. manufactures and markets sterile specialty pharmaceuticals. 
      Akorn has manufacturing facilities located in Decatur, Illinois and 
      Somerset, New Jersey and markets and distributes an extensive line of 
      hospital and ophthalmic pharmaceuticals. Additional information is 
      available at the Company’s website at www.akorn.com.
    
    
      Materials in this press release may contain information that includes or 
      is based upon forward-looking statements within the meaning of the 
      Securities Litigation Reform Act of 1995. Forward-looking statements 
      give our expectations or forecasts of future events. You can identify 
      these statements by the fact that they do not relate strictly to 
      historical or current facts. They use words such as "anticipate," 
      "estimate," "expect," "project," "intend," "plan," "believe," and other 
      words and terms of similar meaning in connection with a discussion of 
      future operating or financial performance. In particular, these include 
      statements relating to future steps we may take, prospective products, 
      future performance or results of current and anticipated products, sales 
      efforts, expenses, the outcome of contingencies such as legal 
      proceedings, and financial results.
    
    
      Any or all of our forward-looking statements here or in other 
      publications may turn out to be wrong. They can be affected by 
      inaccurate assumptions or by known or unknown risks and uncertainties. 
      Many such factors will be important in determining our actual future 
      results. Consequently, no forward-looking statement can be guaranteed. 
      Our actual results may vary materially, and there are not guarantees 
      about the performance of our stock.
    
    
      Any forward-looking statements represent our expectations or forecasts 
      only as of the date they were made and should not be relied upon as 
      representing our expectations or forecasts as of any subsequent date. We 
      undertake no obligation to correct or update any forward-looking 
      statements, whether as a result of new information, future events or 
      otherwise, even if our expectations or forecasts change. You are 
      advised, however, to consult any further disclosures we make on related 
      subjects in our reports filed with the SEC. In particular, you should 
      read the discussion in the section entitled "Cautionary Statement 
      Regarding Forward-Looking Statements" in our most recent Annual Report 
      on Form 10-K, as it may be updated in subsequent reports filed with the 
      SEC. That discussion covers certain risks, uncertainties and possibly 
      inaccurate assumptions that could cause our actual results to differ 
      materially from expected and historical results. Other factors besides 
      those listed there could also adversely affect our results.
    
  
Akorn, Inc. (AMEX:AKN) announced today that its third quarter 2006
earnings release has been scheduled for Monday, October 30, 2006, at
4:00 p.m. (Eastern Time). The Company will also publish the earnings
release on its website at www.akorn.com. In addition, Arthur S.
Przybyl, President and Chief Executive Officer, and Jeffrey A.
Whitnell, Chief Financial Officer, will host an earnings conference
call Monday, October 30, 2006, beginning at 5:00 p.m. (Eastern Time).
The dial-in numbers are [phone] for domestic callers and (913)
981-5550 for international callers.

-0-
*T
 What:       Akorn, Inc. Third Quarter 2006 Earnings Conference Call

 When:       Monday, October 30, 2006 at 5:00 p.m., Eastern Time

 Website:    Live webcast available at www.akorn.com or
             http://www.videonewswire.com/event.asp?id=35878

 Call-in #:  [phone] for domestic callers
             [phone] for international callers

             A replay of the conference call will be posted on the
              Company's website for 30 days following the call.
*T

   About Akorn, Inc.

   Akorn, Inc. manufactures and markets sterile specialty
pharmaceuticals. Akorn has manufacturing facilities located in
Decatur, Illinois and Somerset, New Jersey and markets and distributes
an extensive line of hospital and ophthalmic pharmaceuticals.
Additional information is available at the Company's website at
www.akorn.com.

   Materials in this press release may contain information that
includes or is based upon forward-looking statements within the
meaning of the Securities Litigation Reform Act of 1995.
Forward-looking statements give our expectations or forecasts of
future events. You can identify these statements by the fact that they
do not relate strictly to historical or current facts. They use words
such as "anticipate," "estimate," "expect," "project," "intend,"
"plan," "believe," and other words and terms of similar meaning in
connection with a discussion of future operating or financial
performance. In particular, these include statements relating to
future steps we may take, prospective products, future performance or
results of current and anticipated products, sales efforts, expenses,
the outcome of contingencies such as legal proceedings, and financial
results.

   Any or all of our forward-looking statements here or in other
publications may turn out to be wrong. They can be affected by
inaccurate assumptions or by known or unknown risks and uncertainties.
Many such factors will be important in determining our actual future
results. Consequently, no forward-looking statement can be guaranteed.
Our actual results may vary materially, and there are not guarantees
about the performance of our stock.

   Any forward-looking statements represent our expectations or
forecasts only as of the date they were made and should not be relied
upon as representing our expectations or forecasts as of any
subsequent date. We undertake no obligation to correct or update any
forward-looking statements, whether as a result of new information,
future events or otherwise, even if our expectations or forecasts
change. You are advised, however, to consult any further disclosures
we make on related subjects in our reports filed with the SEC. In
particular, you should read the discussion in the section entitled
"Cautionary Statement Regarding Forward-Looking Statements" in our
most recent Annual Report on Form 10-K, as it may be updated in
subsequent reports filed with the SEC. That discussion covers certain
risks, uncertainties and possibly inaccurate assumptions that could
cause our actual results to differ materially from expected and
historical results. Other factors besides those listed there could
also adversely affect our results.